SEC Form 4 · accession 0000921895-16-004242
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Apr 22, 2016
Accepted (ET)
Apr 26, 2016 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 22, 2016 | S | 3,041 | $2.06 | D | 5,502,849 | D | |
| Common Stock | Apr 22, 2016 | S | 19,759 | $2.07 | D | 5,483,090 | D | |
| Common Stock | Apr 22, 2016 | S | 100 | $2.0725 | D | 5,482,990 | D | |
| Common Stock | Apr 22, 2016 | S | 1,000 | $2.075 | D | 5,481,990 | D | |
| Common Stock | Apr 22, 2016 | S | 3,692 | $2.08 | D | 5,478,298 | D | |
| Common Stock | Apr 22, 2016 | S | 100 | $2.09 | D | 5,478,198 | D | |
| Common Stock | Apr 25, 2016 | S | 1,800 | $2.00 | D | 5,476,398 | D | |
| Common Stock | Apr 25, 2016 | S | 200 | $2.0025 | D | 5,476,198 | D | |
| Common Stock | Apr 25, 2016 | S | 500 | $2.005 | D | 5,475,698 | D | |
| Common Stock | Apr 25, 2016 | S | 7,600 | $2.01 | D | 5,468,098 | D | |
| Common Stock | Apr 25, 2016 | S | 400 | $2.0125 | D | 5,467,698 | D | |
| Common Stock | Apr 25, 2016 | S | 1,200 | $2.015 | D | 5,466,498 | D | |
| Common Stock | Apr 25, 2016 | S | 877 | $2.02 | D | 5,465,621 | D | |
| Common Stock | Apr 25, 2016 | S | 3,400 | $2.05 | D | 5,462,221 | D | |
| Common Stock | Apr 25, 2016 | S | 2,408 | $2.06 | D | 5,459,813 | D | |
| Common Stock | Apr 26, 2016 | S | 4,000 | $1.95 | D | 5,455,813 | D | |
| Common Stock | Apr 26, 2016 | S | 2,500 | $1.97 | D | 5,453,313 | D |
Table II — derivative securities
No Table II lines on this filing.